MERUS LABS
The Merus corporate growth strategy is driven by a product acquisition plan which employs an opportunistic approach to source product acquisition candidates. This approach allows Merus to source pharmaceutical products across broad therapeutic classes which provides access to acquisition targets not available to other players and creates a diversified strategy. Although Merus has a broad therapeutic focus, opportunities will be pursued if the application of a dedicated small scale sales force can deliver incremental product sales growth. The geographic focus will be the United States and Canada
MERUS LABS
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2012-01-01
Address:
Toronto, Ontario, Canada
Country:
Canada
Website Url:
http://www.meruslabs.com
Total Employee:
1+
Status:
Active
Contact:
+1 416 593 3725
Email Addresses:
[email protected]
Total Funding:
69.73 M USD
Technology used in webpage:
SPF Microsoft Azure DNS PHP AuthSMTP NetNames DNS
Current Employees Featured
Stock Details
Official Site Inspections
http://www.meruslabs.com
- Host name: 165.160.13.20
- IP address: 165.160.13.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Merus Labs"
Merus Labs - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +1 416 593 3725 The Merus corporate growth strategy is driven by a product acquisition plan which employs an opportunistic approach to source product acquisition candidates.See details»
Merus Labs - LinkedIn
Merus Labs is an international specialty pharmaceutical company focused on acquiring and optimizing legacy and growth products. The Company leverages its expertise and scalable …See details»
Norgine B.V. completes acquisition of Merus Labs International Inc ...
Jul 17, 2017 · Merus is a specialty pharmaceutical company focused on acquiring and optimizing legacy and growth products. The Company leverages its expertise and scalable platform …See details»
NORGINE B.V. COMPLETES ACQUISITION OF MERUS LABS …
Jul 17, 2017 · Merus is a specialty pharmaceutical company focused on acquiring and optimizing legacy and growth products. The Company leverages its expertise and scalable platform …See details»
Merus Labs International Inc - Company Profile and News
Merus Labs International, Inc. is a specialty pharmaceutical company that acquires established branded pharmaceutical products in Europe and North America.See details»
Merus Labs International - PitchBook
Operator of a specialty pharmaceutical company focused on acquiring and optimizing legacy growth products. The company is engaged in the acquisition and licensing of pharmaceutical …See details»
MERUS LABS AND NORGINE ENTER INTO A DEFINITIVE …
Merus is a specialty pharmaceutical company focused on acquiring and optimizing legacy and growth products. The Company leverages its expertise and scalable platform across Europe, …See details»
Merus Labs International Inc. - VentureRadar
Find out more about Merus Labs International Inc., Major Pharmaceuticals.See details»
Merus Labs, Inc.: Drug pipelines, Patents, Clinical trials - Synapse
Explore Merus Labs, Inc. with its drug pipeline, therapeutic area, technology platform, 3 news.See details»
Merus Labs International - Overview, News & Similar ... - ZoomInfo
Nov 15, 2017 · View Merus Labs International (www.meruslabs.com) location in Ontario, Canada , revenue, industry and description. Find related and similar companies as well as employees …See details»
Merus Labs - Products, Competitors, Financials, Employees, …
Oct 2, 2018 · Merus Labs is a specialty pharmaceutical company with products for oncology, women's health, cardiovascular diseases, urology, and infectious diseases. You're one click …See details»
Merus Labs Inc. - Vancouver, Canada - bionity.com
Merus Labs is a specialty pharmaceutical company engaged in acquisition and licensing of specialty branded Rx and OTC pharmaceutical products.See details»
Merus Labs and Norgine Enter into a Definitive Arrangement
May 11, 2017 · Merus is a specialty pharmaceutical company focused on acquiring and optimizing legacy and growth products. The Company leverages its expertise and scalable platform …See details»
Norgine agrees to buy Merus Labs for $342m
May 11, 2017 · Norgine has entered a definitive agreement to acquire all issued and outstanding common shares of Merus Labs International for $1.65 per share in cash, including the …See details»
Merus Labs, A Specialty Pharmaceutical Company On the Rise, …
Vancouver, British Columbia--(Newsfile Corp. - June 24, 2016) - Barry Fishman, President & CEO of Merus Labs (TSX: MSL) explains how this specialty pharmaceutical company has …See details»
Merus Labs Appoints New Director and Provides European Update …
Mar 27, 2015 · Merus Labs is a specialty pharmaceutical company focused on acquiring established products. The Company leverages its expertise in European and North American …See details»
Norgine B.V. completes acquisition of Merus Labs ... - Newswire
Jul 17, 2017 · Merus, which has approximately 22 employees, becomes a wholly-owned subsidiary of Norgine. Peter Stein, the chief executive officer of Norgine says: "We welcome …See details»
Merus Labs International Inc. announces closing of $60.0
Apr 30, 2015 · The common shares of the Company trade on the Toronto Stock Exchange as ticker 'MSL' and on NASDAQ as ticker 'MSLI'. For more information visit our website at …See details»
Closing in on cancer | Merus
At Merus, we know that time is of the essence. Every day, we bring a sense of urgency and a passion to help patients, by working towards discovering and…See details»
Merus Labs and Norgine Enter into a Definitive Arrangement …
May 11, 2017 · Merus is a specialty pharmaceutical company focused on acquiring and optimizing legacy and growth products. The Company leverages its expertise and scalable platform …See details»